# CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care

> **NCT05502692** · — · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 200 (actual)

## Conditions studied

- Dolutegravir

## Interventions

- **BEHAVIORAL:** CHARACTERISE

## Key facts

- **NCT ID:** NCT05502692
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-12
- **Primary completion:** 2022-12-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05502692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05502692, "CHARACTERISE - A Cross-sectional, Observational Study to Characterise the Transition to Dolutegravir-based Regimens in South Africa in Terms of the Emergence of Obesity, Viral Re-suppression and Integration Into Routine Programme Care". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05502692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*